Current Neuro-Oncology
Volume
26 Number 12
30 June 2024
Home > Publications > Current Neuro-Oncology > Volume 26, Year 2024 > Number 12, 30 June
Onciul R, Toader C, Glavan LA, Covache-Busuioc RA, Bratu BG,
Costin HP, Corlatescu AD, Ciurea AV, Grama M, Idu AA.
Retrospective Analysis of Glioblastoma
Outcomes.
Cureus.
2024 Jun 16;16(6):e62462. doi:
10.7759/cureus.62462. PMID:
38882229. Observational study. ˍ
He Q, Yang Z, Xue B, Song X, Zhang C, Yin C, Li Z, Deng Z, Sun S,
Qiao H, Xie J, Hou Z.
Epilepsy alters
brain networks in patients with insular glioma.
CNS
Neurosci Ther. 2024 Jun 17;30(6):e14805. doi:
10.1111/cns.14805. PMID:
38887197. Observational study. ˍ
Offi M, Gabriele L, Romagnoli G, Lauretti L, Pallini R,
D'Alessandris QG.
The Sybil prophecy:
Searching for predictors of response to bevacizumab in
glioblastoma.
Neuro
Oncol. 2024 Jun 17:noae088. doi:
10.1093/neuonc/noae088. PMID:
38885219. Comment˰ ˍ
Related
articles
-*Hiller-Vallina
S, Mondejar-Ruescas L, Caamaño-Moreno M, Cómitre-Mariano
B, Alcivar-López D, Sepulveda JM, Hernández-Laín
A, Pérez-Núñez Á, Segura-Collar B,
Gargini R.
Sexual-biased
necroinflammation is revealed as a predictor of bevacizumab
benefit in Glioblastoma.
Neuro
Oncol.
2024 Feb 27:noae033. doi:
10.1093/neuonc/noae033. PMID:
38411438. Observational study. ˍ
-Segura-Collar B, Gargini
R.
Sex
differences in glioblastoma based on tumor subtypes.
Neuro
Oncol.
2024 Jun 17:noae089. doi:
10.1093/neuonc/noae089. PMID:
38885250. Reply to comment˰ ˍ
Papusha
L, Zaytseva M, Senchenko M, Sanakoeva A, Panferova A, Sharanda T,
Vilesova I, Tarakanova A, Salnikova E, Usman N, Artemov A,
Karachunskiy A, Maschan A, Hwang E, Packer RJ, Novichkova G, Druy
A.
Cabozantinib
in children with recurrent diffuse gliomas.
Pediatr
Blood Cancer.
2024 Jun 17:e31149. doi:
10.1002/pbc.31149. PMID:
38884269. Case report˰ ˍ
Rahimi
R, Taylor M, Li X, Chen KL, MacLennan G, Murdoch E, Chang L,
Parniani A, Wang P, Chawla A, Fan J, Kim D.
Fetal
dose assessment in a pregnant patient with brain tumor: A
comparative study of proton PBS and 3DCRT/VMAT radiation therapy
techniques.
J
Appl Clin Med Phys.
2024 Jun 17:e14394. doi:
10.1002/acm2.14394. PMID:
38887816. Case report. ˍ
Tang J, Dong Z, Yang L, Yang P, Zhao W, Deng L, Xue J, Cui Y, Li
Q, Tang L, Sheng J, Zhang Y, Zhang H, Chen T, Dong B, Lv X.
The
relationship between prognosis and temporal muscle thickness in
102 patients with glioblastoma.
Sci
Rep. 2024 Jun 17;14(1):13958. doi:
10.1038/s41598-024-64947-z. PMID:
38886495. Observational study. ˍ
Baghani HR, Porouhan P.
Secondary
cancer risk assessment in healthy organs following craniospinal
irradiation.
Int
J Radiat Biol. 2024 Jun 18:1-9. doi:
10.1080/09553002.2024.2369110. PMID:
38889539. Laboratory investigation˰
ˍ
Skadborg
SK, Maarup S, Draghi A, Borch A, Hendriksen S, Mundt F, Pedersen
V, Mann M, Christensen IJ, Skjøth-Rasmussen J, Yde CW,
Kristensen BW, Skovgaard Poulsen H, Hasselbalch B, Svane IM,
Lassen U, Hadrup SR.
Nivolumab
reaches brain lesions in patients with recurrent glioblastoma and
induces T-cell activity and upregulation of checkpoint pathways.
Cancer
Immunol Res.
2024 Jun 18. doi:
10.1158/2326-6066.CIR-23-0959. PMID:
38885356. Observational study. ˍ
Sjövall
K, Ahlberg K, Fessé P, Fransson P, Kristensen I,
Ohlsson-Nevo E, Åkeflo L, Langegård U.
To
become part of the team-patient experiences of participating in
decision-making for a new treatment (proton beam therapy).
Support
Care Cancer.
2024 Jun 18;32(7):442. doi:
10.1007/s00520-024-08631-y. PMID:
38890189. Observational study. ˍ
Yamada N, Kuki I, Fukuoka M, Nukui M, Inoue T, Umaba R, Kunihiro
N, Yamasaki K, Uda T, Fujisaki H, Okazaki S.
Characteristics
of malignant brain tumor-associated epileptic spasms.
Epileptic
Disord. 2024 Jun 18. doi:
10.1002/epd2.20240. PMID:
38888438. Observational
study˰ ˍ
Yuen CA, Bao S, Pekmezci M, Mo F, Kong XT.
Pembrolizumab
in an HIV-infected patient with glioblastoma.
Immunotherapy.
2024 Jun 18:1-9. doi:
10.1080/1750743X.2024.2362566. PMID:
38889068. Case
report˰ ˍ
*Decraene B, Coppens G, Spans L, Solie L, Sciot R, Vanden Bempt I,
De Smet F, De Vleeschouwer S.
A novel
methylation signature predicts extreme long-term survival in
glioblastoma.
J
Neurooncol. 2024 Jun 19. doi:
10.1007/s11060-024-04741-z. PMID:
38898218. Observational study; Laboratory investigation. ˍ
He D, Yang Y, Wu P, Zhu S, Chang H, Zhang C, Shao Q, Yu Z.
Epidemiological trends and factors
associated with survival in patients with medulloblastoma: A
45-year population-based retrospective study.
J
Clin Neurosci. 2024 Jun 19;126:154-161. doi:
10.1016/j.jocn.2024.06.011? PMID:
38901153. Observational
study˰ ˍ
Yoo KH, Marianayagam NJ, Park DJ, Zamarud A, Gu X, Pollom E,
Soltys SG, Meola A, Chang SD.
The Role
of CyberKnife Stereotactic Radiosurgery in Recurrent Cranial
Medulloblastomas across Pediatric and Adult Populations.
J
Clin Med. 2024 Jun 19;13(12):3592. doi:
10.3390/jcm13123592. PMID:
38930121. Observational study. ˍ
Cerron-Vela CR, Gonçalves FG, Tierradentro-García
LO, Viaene AN, Lerebo W, Andronikou S.
A
comprehensive evaluation of imaging features in pediatric spinal
gliomas and their value in predicting tumor grade and histology.
Neuroradiology.
2024 Jun 20. doi:
10.1007/s00234-024-03395-y. PMID:
38902483. Observational study. ˍ
Walbert T, Schultz L, Mikkelsen T, Snyder JM, Phillips J,
Fortunato JT.
Prospective assessment of
end-of-life symptoms and quality of life in patients with
high-grade glioma.
Neurooncol
Pract. 2024 Jun 20;11(6):733-739. doi:
10.1093/nop/npae056. PMID: 39554791.
Observational study˰ ˍ
Zhang S, Patel K, Dusenbery K, Alshreef A, Sterling D, Sloan L,
Reynolds M, Chen CC, Ferreira C.
Dosimetric
evaluation and treatment planning considerations for GammaTile
permanent brain implants - a pilot, institutional experience.
J
Neurooncol. 2024 Jun 20. doi:
10.1007/s11060-024-04631-4. PMID:
38902561. Observational study˰
ˍ
Zhu J, Zhao M, Shi Z, Li Y.
Prevalence
and Radiographic Characteristics of Cerebral Infarction after
Surgery in Patients with Glioma: A Retrospective Study.
Ann
Ital Chir. 2024 Jun 20;95(3):338-346. doi:
10.62713/aic.3275. PMID:
38918970. Observational study. ˍ
*Akhavan D, Subham S, Jeppson JD, Aguilar B, Wong RA, Hibbard JC,
Hui S, Wong JYC, Forman SJ, Alizadeh D, Brown CE.
Evaluation
of the Immunomodulatory Effects of Radiation for Chimeric Antigen
Receptor T Cell Therapy in Glioblastoma Multiforme.
Cells.
2024 Jun 21;13(13):1075. doi:
10.3390/cells13131075. PMID:
38994929.
Laboratory investigation. ˍ
Li YA, Zhao C, Ge JJ, Li C, Xue FJ, Qi SP, Zhao C, Kong CC, Zhang
JP.
Apatinib combined with
temozolomide in diffuse midline glioma: a novel and effective
therapy.
BMC
Cancer. 2024 Jun 21;24(1):754. doi:
10.1186/s12885-024-12373-9. PMID:
38907215. Observational study. ˍ
Shen H, Mei Q, Chai X, Jiang Y, Liu J.
Practical
Nomograms and Risk Stratification System for Predicting the
Overall and Cancer-specific Survival in Patients with Anaplastic
Astrocytoma.
World
Neurosurg. 2024 Jun 21:S1878-8750(24)01034-9. doi:
10.1016/j.wneu.2024.06.076. PMID:
38909753. Observational study˰
ˍ
Thallner R, Gumbinger C, Hohmann A, Wick A, Wick W, Busetto L.
Patient, Relative and Staff
Experiences of Clinical Trial Participation in Neurooncology:
"Maybe You Can Also Show the Positive, No Matter How It
Ends".
Cancer
Manag Res. 2024 Jun 21;16:663-676. doi:
10.2147/CMAR.S447407. PMID:
38919873. Observational study. ˍ
Yu X, Li S, Mai W, Hua X, Sun M, Lai M, Zhang D, Xiao Z, Wang L,
Shi C, Luo L, Cai L.
Pediatric diffuse
intrinsic pontine glioma radiotherapy response prediction: MRI
morphology and T2 intensity-based quantitative analyses.
Eur
Radiol. 2024 Jun 21. doi:
10.1007/s00330-024-10855-9. PMID:
38907098. Observational study. ˍ
Zhang Z, Wu Y, Zhao X, Ji W, Li L, Zhai X, Liang P, Cheng Y, Zhou
J.
Neurosurgical short-term outcomes
for pediatric medulloblastoma patients and molecular correlations:
a 10-year single-center observation cohort study.
Neurosurg
Rev. 2024 Jun 21;47(1):283. doi:
10.1007/s10143-024-02526-6. PMID:
38904885. Observational study˰
ˍ
Liu X, Han T, Wang Y, Liu H, Zhou J.
Prediction
of O(6)-methylguanine-DNA methyltransferase promoter methylation
status in IDH-wildtype glioblastoma using MRI histogram analysis.
Neurosurg
Rev. 2024 Jun 22;47(1):285. doi:
10.1007/s10143-024-02522-w. PMID:
38907038. Observational study˰
ˍ
Ahmeti H, Kiese D, Freitag-Wolf S, Kalab M, Röcken C, Jansen
O, Mehdorn MH, Synowitz M.
IDH1
mutation is associated with improved resection rates,
progression-free survival and overall survival in patients with
anaplastic astrocytomas.
J
Neurooncol. 2024 Jun 23. doi:
10.1007/s11060-024-04743-x. PMID:
38909340. Observational study˰
ˍ
*Hegi ME, Oppong FB, Perry JR, Wick W, Henriksson R, Laperriere
NJ, Gorlia T, Malmström A, Weller M; NCBTSG; NOA; CCTG;
EORTC-BTG.
No benefit from TMZ
treatment in GB with truly unmethylated MGMT promoter: Reanalysis
of the CE.6 and the pooled Nordic/NOA-08 trials in elderly GB
patients.
Neuro
Oncol. 2024 Jun 24:noae108. doi:
10.1093/neuonc/noae108. PMID:
38912869. Observational study. ˍ
*Roux A, Elia A, Hudelist B, Benzakoun J, Dezamis E, Parraga E,
Moiraghi A, Simboli GA, Chretien F, Oppenheim C, Zanello M, Pallud
J.
Prognostic significance of MRI
contrast enhancement in newly diagnosed glioblastoma, IDH-wildtype
according to WHO 2021 classification.
J
Neurooncol. 2024 Jun 24. doi:
10.1007/s11060-024-04747-7. PMID:
38913230. Observational study˰
ˍ
Abu-Arja
MH, Brown AL, Su JM, Okcu MF, Lindsay HB, McGovern SL, McAleer MF,
Grosshans DR, Chintagumpala MM, Paulino AC.
The
cochlear dose and the age at radiotherapy predict severe hearing
loss after passive scattering proton therapy and cisplatin in
children with medulloblastoma.
Neuro
Oncol.
2024 Jun 25:noae114. doi:
10.1093/neuonc/noae114. PMID:
38916058. Observational study˰ ˍ
Fu
W, Li Y, Liu R, Li J.
Incidence
and risk factors of delirium following brain tumor resection: A
retrospective National Inpatient Sample database study.
World
Neurosurg.
2024 Jun 25:S1878-8750(24)01067-2. doi:
10.1016/j.wneu.2024.06.108. PMID:
38936612. Observational study. ˍ
Lion
KM, Jamieson A, Billin A, Jones S, Pinkham MB, Ownsworth T.
'It
was never about me': A qualitative inquiry into the experiences of
psychological support and perceived support needs of family
caregivers of people with high-grade glioma.
Palliat
Med.
2024 Jun 25:2692163241261211. doi:
10.1177/02692163241261211. PMID:
38916277. Observational study. ˍ
*Muhtadi R, Bernhardt D, Multhoff G, Hönikl L, Combs SE,
Krieg SM, Gempt J, Meyer B, Barsegian V, Lindemann M, Kasper M,
Stewart S, Port M, Abend M, Diehl CD, Ostheim P.
Liquid
Biopsy in Whole Blood for Identification of Gene Expression
Patterns (mRNA and miRNA) Associated with Recurrence of
Glioblastoma WHO CNS Grade 4.
Cancers
(Basel). 2024 Jun 26;16(13):2345. doi:
10.3390/cancers16132345. PMID:
39001407.
Laboratory investigation. ˍ
Qasim
R.
Letter
to the editor: Leptomeningeal spread in high-grade gliomas: is
surgery or adjuvant therapy after leptomeningeal spread associated
with survival benefit?
Neurosurg
Rev.
2024 Jun 26;47(1):295. doi:
10.1007/s10143-024-02540-8. PMID:
38922370. Letter˰ ˍ
Weller
J, de Dios E, Katzendobler S, Corell A, Dénes A,
Schmutzer-Sondergeld M, Javanmardi N, Thon N, Tonn JC, Jakola AS.
The
T1/T2 Ratio is Associated With Resectability in Patients With
Isocitrate Dehydrogenase-Mutant Astrocytomas Central Nervous
System World Health Organization Grades 2 and 3.
Neurosurgery.
2024 Jun 26. doi:
10.1227/neu.0000000000003069. PMID:
38920377. Observational study˰ ˍ
*Zemskova O, Yu NY, Leppert J, Rades D.
Prognostic
Factors for Progression-free Survival and Overall Survival After
Recurrence of Glioblastoma.
Anticancer
Res. 2024 Jun 26;44(7):3059-3066. doi:
10.21873/anticanres.17119. PMID:
38925836. Observational
study. ˍ
Dinesh D, Johnson T, P K D, Rengarajan S, Indiran V.
Isocitrate
Dehydrogenase (IDH)-Mutant High-Grade Glioma in the Cerebellum: A
Case Report.
Cureus.
2024 Jun 27;16(6):e63335. doi:
10.7759/cureus.63335. PMID:
39070490. Case report. ˍ
Guidara
S, Seyve A, Poncet D, Leonce C, Bringuier PP, McLeer A, Sturm D,
Cartalat S, Picart T, Ferrari A, Hench J, Frank S, Meyronet D,
Ducray F, Barritault M.
Characteristics
of H3K27M-mutant diffuse gliomas with a non-midline location.
J
Neurooncol.
2024 Jun 27. doi:
10.1007/s11060-024-04733-z. PMID:
38937309. Observational study˰ ˍ
*Monje
M, Mahdi J, Majzner R, Yeom K, Schultz LM, Richards RM, Barsan V,
Song KW, Kamens J, Baggott C, Kunicki M, Lim AS, Reschke A,
Mavroukakis S, Egeler E, Moon J, Patel S, Chinnasamy H, Erickson
C, Jacobs A, Duh AK, Rietberg SP, Tunuguntla R, Klysz DD, Fowler
C, Green S, Beebe B, Carr C, Fujimoto M, Brown AK, Petersen AG,
McIntyre C, Siddiqui A, Lepori-Bui N, Villar K, Pham K, Bove R,
Musa E, Reynolds W, Kuo A, Prabhu S, Rasmussen L, Cornell TT,
Partap S, Fisher PG, Campen CJ, Grant G, Prolo L, Ye X, Sahaf B,
Davis KL, Feldman SA, Ramakrishna S, Mackall C.
Sequential
intravenous and intracerebroventricular GD2-CAR T-cell therapy for
H3K27M-mutated diffuse midline gliomas.
medRxiv
[Preprint].
2024 Jun 27:2024.06.25.24309146. doi:
10.1101/2024.06.25.24309146. PMID:
38978673. Interventional study. ˍ
Stritzelberger
J, Gesmann A, Fuhrmann I, Uhl M, Brandner S, Welte TM, Schembs L,
Dörfler A, Coras R, Adler W, Schwab S, Putz F, Fietkau R,
Distel L, Hamer H.
The
course of tumor-related epilepsy in glioblastoma patients: A
retrospective analysis.
Epilepsy
Behav.
2024 Jun 27;158:109919. doi:
10.1016/j.yebeh.2024.109919. PMID:
38941953. Observational study. ˍ
Vo
KT, Sabnis AJ, Williams PM, Roy-Chowdhuri S, Patton DR, Coffey B,
Reid JM, Piao J, Saguilig L, Alonzo TA, Berg SL, Jaju A, Fox E,
Weigel BJ, Hawkins DS, Mooney MM, Takebe N, Tricoli JV, Janeway
KA, Seibel NL, Parsons DW.
Phase
II Study of Ulixertinib in Children and Young Adults With Tumors
Harboring Activating Mitogen-Activated Protein Kinase Pathway
Alterations: APEC1621J of the National Cancer Institute-Children's
Oncology Group Pediatric MATCH Trial.
JCO
Precis Oncol.
2024 Jun 27;8:e2400103. doi:
10.1200/PO.24.00103. PMID:
38935895. Interventional study˰ ˍ
Zemskova O, Yu NY, Löser A, Leppert J, Rades D.
Evaluation
of Five Prognostic Scores in Patients Receiving Chemoradiation for
Primary Glioblastoma Multiforme.
In
Vivo. 2024 Jun 27;38(4):1806-1813. doi:
10.21873/invivo.13632. PMID:
38936935.
Observational study. ˍ
Düzkalir
AH, Samanci Y, Nabeel AM, Reda WA, Tawadros SR, Abdelkarim K,
El-Shehaby AMN, Emad RM, Martínez Moreno N, Martínez
Álvarez R, Mathieu D, Niranjan A, Lunsford LD, Wei Z,
Shanahan RM, Liscak R, May J, Dono A, Blanco AI, Esquenazi Y,
Dayawansa S, Sheehan J, Tripathi M, Shepard MJ, Wegner RE,
Upadhyay R, Palmer JD, Peker S.
Pleomorphic
Xanthoastrocytoma: Multi-Institutional Evaluation of Stereotactic
Radiosurgery.
Neurosurgery.
2024 Jun 28. doi:
10.1227/neu.0000000000003083. PMID:
38940575. Observational study˰ ˍ
Gendreau
J, Mehkri Y, Kuo C, Chakravarti S, Jimenez MA, Shalom M, Kazemi F,
Mukherjee D.
Clinical
Predictors of Overall Survival in Very Elderly Patients With
Glioblastoma: A National Cancer Database Multivariable Analysis.
Neurosurgery.
2024 Jun 28. doi:
10.1227/neu.0000000000003072. PMID:
38940573. Observational study˰ ˍ
Suh
KJ, Jung EH, Seo J, Ji SY, Hwang K, Han JH, Kim CY, Kim IA, Kim
YJ.
Current
status of advance care planning, palliative care consultation, and
end-of-life care in patients with glioblastoma in South Korea.
Oncologist.
2024 Jun 28:oyae159. doi:
10.1093/oncolo/oyae159. PMID:
38940449. Observational study. ˍ
Zhang T, Wang L.
Intracranial
collision tumor of glioma and metastatic small cell lung cancer: A
case report.
Asian
J Surg. 2024 Jun 28:S1015-9584(24)01279-X. doi:
10.1016/j.asjsur.2024.06.062. PMID:
38942625. Case report. ˍ
Zhao
X, Ren X, Li M, Jiang H, Li M, Wan H, Zhang Y, Lin S, Zhou D.
Subventricular
zone-associated classification in isocitrate
dehydrogenase-wildtype glioblastomas: improved prognostic value
through integration of FLAIR with contrast-enhanced imaging.
J
Neurosurg.
2024 Jun 28:1-10. doi:
10.3171/2024.4.JNS232658. PMID:
38941641. Observational study˰ ˍ
Chaskis E, Silvestri M, Aghakhani N, Parker F, Knafo S.
Management and Outcome of Recurring
Low-Grade Intramedullary Astrocytomas.
Cancers
(Basel). 2024 Jun 30;16(13):2417. doi:
10.3390/cancers16132417. PMID:
39001480.
Observational study. ˍ
Liu H, Duan L, Li Z, Liu Y, Wang Y.
Incidence
and Survival of Patients With Malignant Primary Spinal Cord
Tumors: A Population-Based Analysis.
Neurospine.
2024 Jun 30;21(2):588-595. doi:
10.14245/ns.2347300.650. PMID:
38955530. Observational study. ˍ
Wang Q, Wei W, Ji X, Li J, Wu N, Li J, Sun K, Ma C, Pan H.
Safety
and Efficiency of Anlotinib in Patients with Recurrent Grade 4
Glioma: A Single-Center Retrospective Analysis.
Neurol
India. 2024 Jun 30;72(3):578-584. doi:
10.4103/ni.ni_435_22. PMID:
39041976. Observational study. ˍ
Wang Y, Mu Q, Sheng M, Chen Y, Jian F, Li R.
A
Nomogram for Predicting Overall Survival of Patients With Primary
Spinal Cord Glioblastoma.
Neurospine.
2024 Jun 30;21(2):676-689. doi:
10.14245/ns.2448082.041. PMID:
38955537. Observational study. ˍ